Ideaya Biosciences Inc. logo

Ideaya Biosciences Inc. (IDYA)

Market Closed
11 Jun, 20:00
NASDAQ (NGS) NASDAQ (NGS)
$
28. 84
+1.24
+4.4928%
$
2.77B Market Cap
- P/E Ratio
- Div Yield
1.35M Volume
-1.91 Eps
$ 27.6
Previous Close
Add Transaction
Day Range
27.36 29.54
Year Range
20.5 39.28
Want to track IDYA and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!

Ideaya Biosciences Inc. (IDYA) Statistics

Valuation metrics

Market Cap 2.77B
Enterprise value 2.36B
Trailing P/E (ttm) -17.92
Forward P/E -7.6
PEG ratio -0.41
Price/Sales (ttm) 11.03
Price/Book (mrq) 2.68
Enterprise Value/Revenue 10.46
Enterprise Value/EBITDA -13.18

Overview

Shares outstanding 87.86M
Float 87.01M
Shares short 11.71M
% Held by insiders 0.02%
% Held by institutions 1.11%
Average volume (10 days) 571.67K
Average volume (90 days) 1.16M

Price summary

52-Week low 20.5
52-Week high 39.28
Beta -0.04
50-Day moving average 29.42
200-Day moving average 32.68

Financials

Fiscal year

Fiscal year ends 31 Dec 2025
Most recent quarter (mrq) 31 Mar 2026

Profitability

Profit margin -0.62%
Operating margin -0.81%

Operational effectiveness

Return on assets -0.14%
Return on equity -0.14%

Income Statement

Revenue (ttm) 225.27M
Revenue per share (ttm) 2.54
Quarterly revenue growth (yoy) 0.55%
Gross profit (ttm) -114.27M
EBITDA -180.68M
Net income to common (ttm) -140.06M
Diluted EPS (ttm) -1.58
Quarterly earnings growth (yoy) 0.55%

Balance Sheet

Total cash (mrq) 671.2M
Total cash per share (mrq) 7.57
Total debt (mrq) 28.6M
Total Debt/Equity (mrq) 0.03
Current ratio (mrq) 10.74%
Book value per share (mrq) 10.57

Cash Flow

Cash flow statement -85.93M
Levered free cash flow (LFCF) -57.25M